The GelMA synthesis was carried out as described previously [30,31]. Type-A gelatin (10 % w/v) was solubilized into DPBS with the help of a heating plate at 50 °C. Next, 8 mL of methacrylic anhydride (MA) was carefully dropped into the solution and left to react for 2 h under stirring conditions. To interrupt the functionalization, 100 mL of DPBS was added at 40 °C. To remove the unreacted monomers, the solution was poured into 12–14 kDa dialysis tubing and dialyzed in DI water at 45 ±5 °C for 1 week. The water was changed twice a day. After 7 days, the solution was filtered and freeze-dried at Labconco FreeZone 2.5 L (Labconco Corporation, Kansas City, MO, USA) for 5 days, then stored at − 20 °C until further use. The chemical characterization of GelMA was demonstrated by NMR spectra using DMSO at 35 °C at a frequency of 500 MHz and using a Varian INOVA NMR spectrometer (Varian Medical Systems, Inc., Palo Alto, CA, USA) with a single axis gradient inverse probe.
CHX solutions at different concentrations (0.12, 0.5, 1 %, 2 %, and 5 %) were prepared by dissolving 20 % chlorhexidine digluconate (Lot #BCBM3595V, Sigma-Aldrich) solution in H2O. Lyophilized GelMA was then dissolved into each solution at 15 % (w/v). After dissolving, the photoinitiator (LAP) was added 0.05 % (w/v) at 50 °C under stirring (240 rpm) conditions. Pure GelMA was used as a control (15 % GelMA, hereafter referred as GelMA group).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.